|
|
Article: Eli Lilly and Company Agrees to Pay $1.415 Billion to Resolve Allegations of Off-Label Promotion of Zyprexa.
- Article from:
- Biotech Week
- Article date:
- January 28, 2009
CopyrightCOPYRIGHT 2009 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
American pharmaceutical giant Eli Lilly and Company today agreed to plead guilty and pay $1.415 billion for promoting its drug Zyprexa for uses not approved by the Food and Drug Administration (FDA), the Department of Justice announced. This resolution includes a criminal fine of $515 million, the largest ever in a health care case, and the largest criminal fine for an individual corporation ever imposed in a United States criminal prosecution of any kind. Eli Lilly will also pay up to $800 million in a civil settlement with the federal government and the states (see also Psychiatric Disorders).
Eli Lilly agreed to enter a global resolution with the United ...
Related newspaper, magazine, and journal articles:
|
|
Article: OHIO AND 32 OTHER PARTICIPANTS REACH LANDMARK $62 MILLION ...
US Fed News Service, Including US State News;
October 7, 2008 ;
700+ words
... ... dollar settlement with Eli Lilly and Company arising from ... agreement, alleges that Eli Lilly engaged in unfair and ... year investigation, Eli Lilly agreed to change how ... Administration ("FDA") has approved Zyprexa for the treatment of ...
|
|